Extramedullary Manifestation in Multiple Myeloma Bears High Incidence of Poor Cytogenetic Aberration and Novel Agents Resistance

BioMed Research International - United States
doi 10.1155/2015/787809
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Concurrent Myelomatous Pleural Effusion and Extramedullary Mediastinal Involvement as an Initial Manifestation of Multiple Myeloma

American Journal of Case Reports
Medicine
2016English

Incidence and Clinical Features of Extramedullary Multiple Myeloma in Patients Who Underwent Stem Cell Transplantation

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Incidence and Clinical Features of Extramedullary Multiple Myeloma in Patients Who Underwent Stem Cell Transplantation

British Journal of Haematology
Hematology
2015English

Multiple Myeloma: Future Directions in Autologous Transplantation and Novel Agents

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Results of Cytogenetic and Molecular Cytogenetic Studies in Relapce/Refractory of Multiple Myeloma

Innovative Biosystems and Bioengineering
2018English

High Expression of UBE2T Predicts Poor Prognosis and Survival in Multiple Myeloma

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2019English

Scrotal and Orbital Involvement in Extramedullary De-Differentiated Multiple Myeloma

Canadian Journal of General Internal Medicine
1970English

Value of Novel Agents and Intensive Therapy for Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2013English

Chromothripsis 18 in Multiple Myeloma Patient With Rapid Extramedullary Relapse

Molecular Cytogenetics
BiochemistryMolecular MedicineGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy